On 30 May 2024, on the margins of WHA77, IFPMA hosted an event on the socio-economic value of adult vaccination.
Read more
On the margins of the 77th World Health Assembly, we hosted a satellite symposium on accelerating action against vector-borne and infectious diseases at the Geneva Health Forum on 29 May.
Read more
On 14 May, IFPMA and Foreign Policy convened a high-level event on the margins of the multistakeholder hearing on AMR in New York City.
Read more
On 18 March, the first day of the 9th Meeting of the Intergovernmental Negotiating Body, we hosted a side event to share the biopharmaceutical industry’s commitments on delivering equitable access to medicines and vaccines, building on the Berlin Declaration.
Read more
IFPMA is attending DIA Europe 2024, leading a session on the African Medicines Agency. IFPMA representatives will also discuss topics related to global regulatory collaboration and regulatory reliance, and the use of new digital tools and artificial intelligence to evolve manufacturing practices.
Read more
This breakfast session at the World Health Summit brings together key scientific actors across the world who are engaged in day-to-day R&D based on pathogens, such as in laboratories, databanks, and the pharmaceutical industry to discuss the necessary role of pathogens in a pandemic.
Read more
With a focus on three global health topics – pandemic prevention, preparedness and response, universal health coverage, and tuberculosis – at UNGA78, IFPMA hosted a flagship side event to discuss how innovation can be at the heart of our plans to strengthen global health security.
Read more